Prosecution Insights
Last updated: April 19, 2026

Bruker Spatial Biology Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18435438 ANALYSIS OF NUCLEIC ACIDS ASSOCIATED WITH SINGLE CELLS USING NUCLEIC ACID BARCODES RYAN, DOUGLAS CHARLES 1635 Final Rejection Feb 07, 2024
18245589 CHEMICAL COMPOSITIONS AND METHODS OF USING THE SAME SISSON, BRADLEY L 1682 Non-Final OA Mar 16, 2023
18172771 CHEMICAL COMPOSITIONS AND METHODS OF USE KIM, SEONG JONG 1621 Non-Final OA Feb 22, 2023
18163810 OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP LU, CHENG 1642 Non-Final OA Feb 02, 2023
18010873 COMPOSITIONS AND METHODS FOR IN SITU SINGLE CELL ANALYSIS USING ENZYMATIC NUCLEIC ACID EXTENSION VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 Final Rejection Dec 16, 2022

Managing Bruker Spatial Biology Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month